webinar register page

Webinar banner
N=1 Collaborative Seminar Series - Feb 13
The most important aspects of the guidelines for N=1 exon skipping design and in vitro development by Annemieke Aartsma-Rus

Feb 13, 2023 10:30 AM in Eastern Time (US and Canada)

* Required information


Annemieke Aartsma-Rus, PhD
@Dutch Center for RNA Therapeutics
Prof. Dr. Annemieke Aartsma-Rus is a professor of Translational Genetics at the Department of Human Genetics of the Leiden University Medical Center. She played an important role in the development of antisense mediated exon skipping for Duchenne muscular dystrophy during her PhD research (2000-2004) at the Leiden University Medical Center (the Netherlands). As of December 2007 she became leader of the “DMD exon skip group”. Since 2013 she has a visiting professorship at the Institute of Genetic Medicine of Newcastle University (UK). In 2020 she co-founded the Dutch Center for RNA Therapeutics (DCRT), a not-for-profit academic collaboration aiming to develop clinical treatment with exon skipping therapies for eligible patients with unique mutations.